Minimizing Tumor Volume for a Mathematical Model of Anti-Angiogenesis with Linear Pharmacokinetics
暂无分享,去创建一个
[1] L. Wein,et al. Optimal scheduling of radiotherapy and angiogenic inhibitors , 2003, Bulletin of mathematical biology.
[2] Urszula Ledzewicz,et al. Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment. , 2010, Mathematical medicine and biology : a journal of the IMA.
[3] I. B. Borel Rinkes,et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. , 2000, Cancer research.
[4] A. Friedman. Cancer Models and Their Mathematical Analysis , 2006 .
[5] Urszula Ledzewicz,et al. No . 4 B Singular controls and chattering arcs in optimal control problems arising in biomedicine , 2010 .
[6] E. Afenya. Using mathematical modeling as a resource in clinical trials. , 2005, Mathematical biosciences and engineering : MBE.
[7] U. Ledzewicz,et al. The influence of pk/pd on the structure of optimal controls in cancer chemotherapy models. , 2005, Mathematical biosciences and engineering : MBE.
[8] V. Boltyanskii. Sufficient Conditions for Optimality and the Justification of the Dynamic Programming Method , 1966 .
[9] Urszula Ledzewicz,et al. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy. , 2007, Mathematical biosciences.
[10] U. Ledzewicz,et al. ANTI-ANGIOGENIC THERAPY IN CANCER TREATMENT AS AN OPTIMAL CONTROL PROBLEM , 2007 .
[11] Urszula Ledzewicz,et al. AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem , 2007, SIAM J. Control. Optim..
[12] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[13] H. Maurer,et al. Optimization methods for the verification of second order sufficient conditions for bang–bang controls , 2005 .
[14] Richard Bellman,et al. Introduction to the mathematical theory of control processes , 1967 .
[15] Urszula Ledzewicz,et al. Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models , 2009 .
[16] Vladimir Borisov,et al. Theory of Chattering Control , 1994 .
[17] R. D'Amato,et al. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. , 2001, Cancer research.
[18] A. Fuller. Study of an Optimum Non-linear Control System† , 1963 .
[19] D. Wishart. Introduction to the Mathematical Theory of Control Processes. Volume 1—Linear Equations and Quadratic Criteria , 1969 .
[20] M. I. Zelikin,et al. Theory of Chattering Control: with applications to Astronautics, Robotics, Economics, and Engineering , 1994 .
[21] J. P. Mcdanell,et al. Necessary Conditions Joining Optimal Singular and Nonsingular Subarcs , 1971 .
[22] H. Schättler,et al. A Synthesis of Optimal Controls for a Model of Tumor Growth under Angiogenic Inhibitors , 2005, Proceedings of the 44th IEEE Conference on Decision and Control.
[23] M. Chyba,et al. Singular Trajectories and Their Role in Control Theory , 2003, IEEE Transactions on Automatic Control.